Back
Karyopharm Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
KPTI
Karyopharm Therapeutics, Inc.
Last Price:
$6.91
Seasonality Move:
10%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KPTI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Karyopharm Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.6 | Buy |
| 20-day SMA: | 6.07 | Buy |
| 50-day SMA: | 5.95 | Buy |
| 200-day SMA: | 5.46 | Buy |
| 8-day EMA: | 6.48 | Buy |
| 20-day EMA: | 6.22 | Buy |
| 50-day EMA: | 6.03 | Buy |
| 200-day EMA: | 6.59 | Buy |
Karyopharm Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 61.3 | Buy |
| Chaikin Money Flow: | 312381 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.55 - 6.51) | Buy |
| Bollinger Bands (100): | (5.08 - 6.76) | Buy |
Karyopharm Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Karyopharm Therapeutics, Inc. Stock
Is Karyopharm Therapeutics, Inc. Stock a Buy?
-
Karyopharm Therapeutics, Inc. share price is 6.94 while KPTI 8-day simple moving average is 6.60, which is a Buy signal.
-
The stock price of KPTI is 6.94 while Karyopharm Therapeutics, Inc. 20-day SMA is 6.07, which makes it a Buy.
-
Karyopharm Therapeutics, Inc. 50-day simple moving average is 5.95 while KPTI share price is 6.94, making it a Buy technically.
-
KPTI stock price is 6.94 and Karyopharm Therapeutics, Inc. 200-day simple moving average is 5.46, creating a Buy signal.
KPTI Technical Analysis vs Fundamental Analysis
Buy
57
Karyopharm Therapeutics, Inc. (KPTI)
is a Buy
Is Karyopharm Therapeutics, Inc. a Buy or a Sell?
-
Karyopharm Therapeutics, Inc. stock is rated a BuyThe current Karyopharm Therapeutics, Inc. [KPTI] share price is $6.94. The Score for KPTI is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Karyopharm Therapeutics, Inc. Stock Info
Market Cap:
118.3M
Price in USD:
6.94
Share Volume:
580.1K
Karyopharm Therapeutics, Inc. 52-Week Range
52-Week High:
12.45
52-Week Low:
3.51
Buy
57
Karyopharm Therapeutics, Inc. (KPTI)
is a Buy
Karyopharm Therapeutics, Inc. Share Price Forecast
-
What is the Karyopharm Therapeutics, Inc. stock price today?The Karyopharm Therapeutics, Inc. stock price is 6.94 USD today.
-
Will KPTI stock go up or go down?Karyopharm Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Karyopharm Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Karyopharm Therapeutics, Inc. is not overvalued.
Is Karyopharm Therapeutics, Inc. Stock a Buy?
-
Karyopharm Therapeutics, Inc. share price is 6.94 while KPTI 8-day exponential moving average is 6.48, which is a Buy signal.
-
The stock price of KPTI is 6.94 while Karyopharm Therapeutics, Inc. 20-day EMA is 6.22, which makes it a Buy.
-
Karyopharm Therapeutics, Inc. 50-day exponential moving average is 6.03 while KPTI share price is 6.94, making it a Buy technically.
-
KPTI stock price is 6.94 and Karyopharm Therapeutics, Inc. 200-day simple moving average is 6.59, creating a Buy signal.
Fundamental Analysis of Karyopharm Therapeutics, Inc.
Is Karyopharm Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $2.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.81 per share, and an increase next year of $7.17 per share.
Technical Analysis of Karyopharm Therapeutics, Inc.
Should I short Karyopharm Therapeutics, Inc. stock?
-
KPTI Moving Average Covergence Divergence (MACD) indicator is 0.22, suggesting Karyopharm Therapeutics, Inc. is a Buy
-
Karyopharm Therapeutics, Inc. Relative Strength Index (RSI) is 61.3, which suggest Karyopharm Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Karyopharm Therapeutics, Inc. is (5.55 - 6.51), which suggest Karyopharm Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Karyopharm Therapeutics, Inc. is (5.08 - 6.76), which suggest Karyopharm Therapeutics, Inc. is a Buy
* Karyopharm Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.